The individual contributions of bla B, bla GOB and bla CME on MICs of β-lactams in Elizabethkingia anophelis
Journal of Antimicrobial Chemotherapy · 01.07.2024 · 79 (7) · 1577-1580
DOI: 10.1093/jac/dkae137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 13.05.2024. Verfasst von Pei-Jing Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, beta-Lactamases, Flavobacteriaceae, Flavobacteriaceae Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHRI, Ministry of Science and Technology.
Abstract (Originalsprache)
Background
The blaB, blaGOB and blaCME genes are thought to confer β-lactam resistance to Elizabethkingia anophelis, based on experiments conducted primarily on Escherichia coli.
Objectives
To determine the individual contributions of β-lactamase genes to increased MICs in E. anophelis and to assess their impact on the in vivo efficacy of carbapenem therapy.
Methods
Scarless gene deletion of one or more β-lactamase gene(s) was performed in three clinical E. anophelis isolates. MICs were determined by broth microdilution. Hydrolytic activity and expressions of β-lactamase genes were measured by an enzymatic assay and quantitative RT–PCR, respectively. In vivo efficacy was determined using Galleria mellonella and murine thigh infection models.
Results
The presence of blaB resulted in >16-fold increases, while blaGOB caused 4–16-fold increases of carbapenem MICs. Hydrolysis of carbapenems was highest in lysates of blaB-positive strains, possibly due to the constitutionally higher expression of blaB. Imipenem was ineffective against blaB-positive isolates in vivo in terms of improvement of the survival of wax moth larvae and reduction of murine bacterial load. The deletion of blaB restored the efficacy of imipenem. The blaB gene was also responsible for a >4-fold increase of ampicillin/sulbactam and piperacillin/tazobactam MICs. The presence of blaCME, but not blaB or blaGOB, increased the MICs of ceftazidime and cefepime by 8–16- and 4–8-fold, respectively.
Conclusions
The constitutionally and highly expressed blaB gene in E. anophelis was responsible for increased MICs of carbapenems and led to their poor in vivo efficacy. blaCME increased the MICs of ceftazidime and cefepime.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan.
- Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan.
- Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan.
- Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
ORCID-Profile: Shu-Chen Kuo
Förderung
- NHRI
- Ministry of Science and Technology
Zitieren
APA
Chen, P. J., Tan, M. C., Huang, W. C., Hsu, S. Y., Chen, T. L., Yang, C. Y., & Kuo, S. C. (2024). The individual contributions of bla B, bla GOB and bla CME on MICs of β-lactams in Elizabethkingia anophelis. Journal of Antimicrobial Chemotherapy, 79(7), 1577-1580. https://doi.org/10.1093/jac/dkae137
Vancouver
Chen PJ, Tan MC, Huang WC, Hsu SY, Chen TL, Yang CY, et al. The individual contributions of bla B, bla GOB and bla CME on MICs of β-lactams in Elizabethkingia anophelis. Journal of Antimicrobial Chemotherapy. 2024;79(7):1577-1580. doi:10.1093/jac/dkae137
BibTeX
@article{Chen2024,
author = {Chen, Pei-Jing and Tan, Mei-Chen and Huang, Wei-Cheng and Hsu, Shu-Yuan and Chen, Te-Li and Yang, Chiou-Ying and Kuo, Shu-Chen},
title = {The individual contributions of bla B, bla GOB and bla CME on MICs of β-lactams in Elizabethkingia anophelis},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
volume = {79},
number = {7},
pages = {1577--1580},
doi = {10.1093/jac/dkae137}
}
EUVIMED